Document is current
Any future updates will be listed below
-
Authors
Kamboj, Akshita https://orcid.org/0009-0005-9047-7236
Thielmann, Jennifer https://orcid.org/0000-0001-5121-404X
Delfan, Saba https://orcid.org/0000-0001-8107-9483
Kloppe, Tim https://orcid.org/0000-0001-6932-4140
Schulz, Philipp https://orcid.org/0000-0003-4401-5901
Manohar, Murli
Schroeder, Frank C. https://orcid.org/0000-0002-4420-0237
Klessig, Daniel F. https://orcid.org/0000-0002-1315-5920
Kogel, Karl-Heinz https://orcid.org/0000-0003-1226-003X
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (WheatInterfere)
Justus-Liebig-Universität Gießen
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 2 June 2024
First Online: 2 July 2024
Declarations
:
: The research described in the manuscript was not funded by private partners or industry. Authors Akshita Kamboj (she), Jennifer Thielmann (she), Saba Delfan (she), and Karl-Heinz Koge (he) declare that they have no conflict of interest. Authors Murli Manohar, Frank Schroeder, and Daniel Klessig are co-founders of Ascribe Bioscience, a company that develops plant treatments based on small molecules from microbiota.
: All authors declare consent of publication.
